NCT04705142View on ClinicalTrials.gov

Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
HIE
Interventions
DRUG

MgSo4

Before and during administration of MgSO4, B.P, Capillary refill time, Heart rate and respiratory rate will be assessed closely i-e on 10 minutes interval, infusion of MgSO4 will be give over 30 minutes and baby will be monitored every 15 minutes interval after completion of infusion as well for 1 hour.

Trial Locations (1)

54000

Services Institute of Medical Sciences, Lahore, Lahore

All Listed Sponsors
lead

Services Institute of Medical Sciences, Pakistan

OTHER_GOV

NCT04705142 - Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE) | Biotech Hunter | Biotech Hunter